Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
LETTER TO THE EDITOR
Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide
- Pages: 232-233
- First Published: 05 November 2023
PERSPECTIVES
Physical activity in the new era of antiobesity medications
- Pages: 234-236
- First Published: 17 October 2023
Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
- Pages: 237-239
- First Published: 03 December 2023
REVIEW
Obesity Biology and Integrated Physiology
Update on N6-methyladenosine methylation in obesity-related diseases
- Pages: 240-251
- First Published: 21 November 2023
ORIGINAL ARTICLES
Clinical Trials and Investigations
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study
- Pages: 252-261
- First Published: 02 November 2023
Effects of energy loads on energy and nutrient absorption rates and gut microbiome in humans: A randomized crossover trial
- Pages: 262-272
- First Published: 05 November 2023
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis
- Pages: 273-280
- First Published: 21 November 2023
Effects of exercise on sleep in children with overweight/obesity: a randomized clinical trial
- Pages: 281-290
- First Published: 19 December 2023
Obesity Biology and Integrated Physiology
Elevated BMI impacts brain-state dynamics within the sensorimotor-to-transmodal hierarchy
- Pages: 291-303
- First Published: 25 January 2024
Metabolite signature of diabetes remission in individuals with obesity undergoing weight loss interventions
- Pages: 304-314
- First Published: 14 November 2023
Obesity alters the circadian profiles of energy metabolism and glucose regulation in humans
- Pages: 315-323
- First Published: 15 November 2023
A newly identified compound activating UCP1 inhibits obesity and its related metabolic disorders
- Pages: 324-338
- First Published: 17 November 2023
NADPH oxidase 4 in mouse β cells participates in inflammation on chronic nutrient overload
- Pages: 339-351
- First Published: 12 December 2023

Redox signaling is involved in insulin secretion on glucose induction in pancreatic β cells (NADPH oxidase isoform 4 [NOX4] is the major player), whereas oxidative stress in β cells leads to the development of type 2 diabetes. Sustained activation of NOX4 in β cells by chronic overnutrition induces the inflammasome and IL-1β production, leading to macrophage activation and local inflammation. Thus, βNOX4−/− mice do not develop chronic inflammation on HFD, suggesting the role of sustained NOX4 activation in diabetes development. Redox regulation in β cells is an important player in their physiology and NOX4 might be a potential pharmacological target during chronic nutritional overload.
Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery
- Pages: 352-362
- First Published: 29 November 2023
Novel markers and networks related to restored skeletal muscle transcriptome after bariatric surgery
- Pages: 363-375
- First Published: 12 December 2023
Pediatric Obesity
Associations between BMI in youth and site-specific cancer in men—A cohort study with register linkage
- Pages: 376-389
- First Published: 06 November 2023
Gentrification and childhood obesity: Evidence from New York City public school students in public housing
- Pages: 390-397
- First Published: 20 November 2023
Epidemiology/Genetics
Observational and genetic associations of adiposity with cardiopulmonary multimorbidity: Linear and nonlinear Mendelian randomization analysis
- Pages: 398-408
- First Published: 05 November 2023
Plant-based dietary patterns and genetic susceptibility to obesity in the CARTaGENE cohort
- Pages: 409-422
- First Published: 06 December 2023
Branched-chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis
- Pages: 423-435
- First Published: 25 January 2024